Sema4 Signal Delivers Data-driven Precision Oncology Solutions
Sema4 Signal provides precision oncology solutions with advanced analytics, digital tools, and exome-based somatic and hereditary cancer genomic tests.
Read MorePosted by Laurie Bonner | Jul 9, 2020 | Cancer, Digital Pathology, Information Technology |
Sema4 Signal provides precision oncology solutions with advanced analytics, digital tools, and exome-based somatic and hereditary cancer genomic tests.
Read MorePosted by Laurie Bonner | Jul 2, 2020 | Diabetes & Metabolic Diseases, Microbiology |
Stool microbes make a challenging diagnosis easier.
Read MorePosted by Laurie Bonner | Jul 1, 2020 | Disease States, Molecular Diagnostics |
Clinicians seeing patients remotely can now offer home DNA sample collection
Read MorePosted by Laurie Bonner | Jun 27, 2020 | Covid 19 |
A report from the Howard Hughes Medical Institute explores the need for—and barriers to—laboratory testing for SARS-CoV-2.
Read MorePosted by Laurie Bonner | Jun 23, 2020 | Covid 19 |
FDA has outlined the steps for a test to be authorized for broad screening of asymptomatic individuals.
Read More